At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover, Germany, reviews ongoing clinical trials for the treatment of patients with metastatic renal cell carcinoma, including investigations of nivolumab versus everolimus; cabozantinib versus everolimus; and lenvatinib combined with everolimus.
European Medical Journal
Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Advertisement